Oncoscience GmbH develops therapeutic options for rare diseases in oncology.
Cancer is one of the leading causes of death worldwide and e.g. in Germany the second leading cause of death after cardiovascular diseases.
The results of an international clinical trial were published in March 2019. Forty-two children aged 3 to 20 years suffe...
Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingd...
Oncoscience GmbH announced today that it has entered into an exclusive supply and distribution agreement with ...